Research and Markets, the world's leading source for international market research reports and data, has seen a surge in demand for its services from pharmaceutical and healthcare companies, as the se...
DUBLIN: Research and Markets, the world's leading source for international market research reports and data, has seen a surge in demand for its services from pharmaceutical and healthcare companies, as the sector grapples with the disruptive pace of artificial intelligence (AI), regulatory shifts, and an overwhelming volume of market information.
With more than 650 publishing partners, Research and Markets stands apart as a trusted advocate for its clients. It helps global pharmaceutical companies navigate a fragmented, often confusing research landscape and make informed decisions with confidence. In a time when questions around quality, trust, and bias are front and centre, the company’s independent, client-first model is proving more valuable than ever.
“We’re not here to push a particular publisher. We’re here to help our clients find the intelligence that best suits their needs, whether that’s a global forecast from a top-tier provider or a specialist report from a niche supplier that’s hard to access anywhere else,” said Ross Glover, CEO of Research and Markets. “It’s about independence, experience, and a relentless focus on quality.”
From multinational pharmaceutical companies to emerging biotech firms, Research and Markets supports a broad range of organisations across the healthcare and life sciences sectors. Clients include leading drug manufacturers, contract research and manufacturing organisations, and healthcare-focused investors, all of whom rely on timely, credible market intelligence to guide strategy, innovation, and investment decisions.
Within those organisations, the platform is relied upon by a wide array of roles, including:
Beyond providing access to a vast catalogue of research, Research and Markets also simplifies the procurement process. Clients benefit from a single point of access to hundreds of suppliers, reducing friction for purchasing teams, streamlining internal workflows, and ensuring compliance with procurement policies. This is particularly important for large, global organisations managing multiple business units and complex research needs.
“Procurement teams love that they don’t need to onboard dozens of niche suppliers individually,” said Glover. “With us, they have one contract, one relationship, and access to everything from mainstream to highly specialised intelligence.”
Key topics currently driving demand include:
“Our role is to be a partner in progress,” added Glover. “We don’t just help clients buy research. We help them buy well. We understand the space, we know the sources, and we work hard every day to match organisations with insights that actually move their strategy forward.”
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Today, Securonix, a five-time Leader in the Gartner® Magic Quadrant™ for Security Information and Event Management (SIEM), announced the acquisition of…
#NextGenHealthcare--NextGen Healthcare, Inc. (“NextGen Healthcare” or the “Company”), a leading provider of innovative, cloud-based healthcare technology…
Anjuna, a leader in Confidential Computing and AI Data Fusion Clean Rooms, today announced the addition of a new top five global bank to its growing roster…
PubNub, the leader in real-time interactive apps, unveiled the next evolution of its platform. It introduces AI-native development, real-time decision…